182 related articles for article (PubMed ID: 15319826)
21. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.
Huttly W; Rudnicka A; Wald NJ
Prenat Diagn; 2004 Oct; 24(10):804-7. PubMed ID: 15503275
[TBL] [Abstract][Full Text] [Related]
22. Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity.
Kang JH; Farina A; Park JH; Kim SH; Kim JY; Rizzo N; Elmakky A; Jun HS; Hahn WB; Cha DH
Prenat Diagn; 2008 Aug; 28(8):704-9. PubMed ID: 18655226
[TBL] [Abstract][Full Text] [Related]
23. First-trimester maternal serum immunoreactive inhibin in chromosomally normal and abnormal pregnancies. Dutch Working Party on Prenatal Diagnosis.
Van Lith JM; Mantingh A; Pratt JJ
Obstet Gynecol; 1994 May; 83(5 Pt 1):661-4. PubMed ID: 8164921
[TBL] [Abstract][Full Text] [Related]
24. The effect of fetal gender on second-trimester maternal serum inhibin-A concentration.
Lam YH; Tang MH
Prenat Diagn; 2001 Aug; 21(8):662-4. PubMed ID: 11536266
[TBL] [Abstract][Full Text] [Related]
25. Quad screen as a predictor of adverse pregnancy outcome.
Dugoff L; Hobbins JC; Malone FD; Vidaver J; Sullivan L; Canick JA; Lambert-Messerlian GM; Porter TF; Luthy DA; Comstock CH; Saade G; Eddleman K; Merkatz IR; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2005 Aug; 106(2):260-7. PubMed ID: 16055573
[TBL] [Abstract][Full Text] [Related]
26. Three-stage contingent screening for Down syndrome.
Wright D; Bradbury I; Cuckle H; Gardosi J; Tonks A; Standing S; Benn P
Prenat Diagn; 2006 Jun; 26(6):528-34. PubMed ID: 16634118
[TBL] [Abstract][Full Text] [Related]
27. Second-trimester maternal serum markers in twin pregnancy with complete mole: report of 2 cases.
Lambert-Messerlian G; Pinar H; Rubin LP; De Paepe ME; Tantravahi U; Steinhoff MM; Russell M; Canick JA
Pediatr Dev Pathol; 2005; 8(2):230-4. PubMed ID: 15765203
[TBL] [Abstract][Full Text] [Related]
28. Inhibin A measurement using an automated assay platform.
Lambert-Messerlian GM; Palomaki GE; Canick JA
Prenat Diagn; 2008 May; 28(5):399-403. PubMed ID: 18395865
[TBL] [Abstract][Full Text] [Related]
29. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
Rice JD; McIntosh SF; Halstead AC
Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
[TBL] [Abstract][Full Text] [Related]
30. Inhibins and activins in human fetal abnormalities.
Lambert-Messerlian GM; Pinar H; Laprade E; Tantravahi U; Schneyer A; Canick JA
Mol Cell Endocrinol; 2004 Oct; 225(1-2):101-8. PubMed ID: 15451574
[TBL] [Abstract][Full Text] [Related]
31. Elevated second-trimester dimeric inhibin A levels identify Down syndrome pregnancies.
Wenstrom KD; Owen J; Chu DC; Boots L
Am J Obstet Gynecol; 1997 Nov; 177(5):992-6. PubMed ID: 9396881
[TBL] [Abstract][Full Text] [Related]
32. Prenatal screening for Down syndrome: the problem of recurrent false-positives.
Wald NJ; Huttly WJ; Rudnicka AR
Prenat Diagn; 2004 May; 24(5):389-92. PubMed ID: 15164416
[TBL] [Abstract][Full Text] [Related]
33. Sequential pathways of testing after first-trimester screening for trisomy 21.
Platt LD; Greene N; Johnson A; Zachary J; Thom E; Krantz D; Simpson JL; Silver RK; Snijders RJ; Goetzl L; Pergament E; Filkins K; Mahoney MJ; Hogge WA; Wilson RD; Mohide P; Hershey D; MacGregor S; Bahado-Singh R; Jackson LG; Wapner R;
Obstet Gynecol; 2004 Oct; 104(4):661-6. PubMed ID: 15458882
[TBL] [Abstract][Full Text] [Related]
34. Using Down syndrome serum screening results to predict low birthweight.
Huang T; Alberman E; Watt HC; Wald NJ
Prenat Diagn; 2003 May; 23(5):420-6. PubMed ID: 12749041
[TBL] [Abstract][Full Text] [Related]
35. Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy.
Palomaki GE; Neveux LM; Haddow JE; Wyatt P
Prenat Diagn; 2007 Sep; 27(9):808-13. PubMed ID: 17590886
[TBL] [Abstract][Full Text] [Related]
36. [Specificity of biochemical markers of pregnancy second trimester].
Salazar López R; Ibarra Gallardo AL; Iduma Meléndrez M; Leyva Bojórquez R
Ginecol Obstet Mex; 2007 Oct; 75(10):608-14. PubMed ID: 18800579
[TBL] [Abstract][Full Text] [Related]
37. Maternal serum activin A and follistatin levels in pregnancies with Down syndrome.
Cuckle HS; Sehmi I; Jones R; Evans LW
Prenat Diagn; 1999 Jun; 19(6):513-6. PubMed ID: 10416964
[TBL] [Abstract][Full Text] [Related]
38. Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies.
Huang T; Boucher K; Summers AM
Prenat Diagn; 2007 Dec; 27(12):1138-42. PubMed ID: 17960787
[TBL] [Abstract][Full Text] [Related]
39. Stability of first- and second-trimester serum markers after storage and shipment.
Lambert-Messerlian GM; Eklund EE; Malone FD; Palomaki GE; Canick JA; D'Alton ME
Prenat Diagn; 2006 Jan; 26(1):17-21. PubMed ID: 16378319
[TBL] [Abstract][Full Text] [Related]
40. Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome.
Wenstrom KD; Owen J; Chu DC; Boots L
Am J Obstet Gynecol; 1997 Nov; 177(5):987-91. PubMed ID: 9396880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
